Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
Liwei Lang(Augusta University), Yong Teng(Augusta University)
Cited by 62
Related Papers
Is It Time to Start Transitioning From 2D to 3D Cell Culture?
|Frontiers in Molecular Biosciences|2020|1.6k
CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
|Journal of Experimental & Clinical Cancer Research|2020|138
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
|Journal of Experimental & Clinical Cancer Research|2023|57
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
|Journal of Hematology & Oncology|2019|52
Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
|Journal of Experimental & Clinical Cancer Research|2019|49